Life sciences company Thermo Fisher Scientific (NYSE: TMO) played an instrumental role in delivering COVID-19 treatments to the world's population. With healthcare spending on the rise, Thermo Fisher is expanding its services in a bid to capture even more of the market. To help address this need, The White House released a Pandemic Preparedness Plan and hopes to increase biodefense spending.
Thermo Fisher Scientific (TMO) closed the most recent trading day at $543.28, moving +1.37% from the previous trading session.
Thermo Fisher Scientific (TMO) closed at $544.81 in the latest trading session, marking a +0.78% move from the prior day.